These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20689132)

  • 81. Discovery of diagnostic serum biomarkers of gastric cancer using proteomics.
    Lam KW; Lo SC
    Proteomics Clin Appl; 2008 Feb; 2(2):219-28. PubMed ID: 21136826
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Glycomic analysis of ovarian cancer: past, present, and future.
    Abbott KL
    Cancer Biomark; 2010-2011; 8(4-5):273-80. PubMed ID: 22045358
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature.
    Posadas EM; Davidson B; Kohn EC
    Curr Opin Oncol; 2004 Sep; 16(5):478-84. PubMed ID: 15314519
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Current status on microRNAs as biomarkers for ovarian cancer.
    Prahm KP; Novotny GW; Høgdall C; Høgdall E
    APMIS; 2016 May; 124(5):337-55. PubMed ID: 26809719
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Proteomics as a tool for biomarker discovery.
    Kohn EC; Azad N; Annunziata C; Dhamoon AS; Whiteley G
    Dis Markers; 2007; 23(5-6):411-7. PubMed ID: 18057524
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Tumor markers for early detection of ovarian cancer.
    Ren J; Cai H; Li Y; Zhang X; Liu Z; Wang JS; Hwa YL; Zhang Y; Yang Y; Li Y; Jiang SW
    Expert Rev Mol Diagn; 2010 Sep; 10(6):787-98. PubMed ID: 20843202
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy.
    Deng J; Wang L; Ni J; Beretov J; Wasinger V; Wu D; Duan W; Graham P; Li Y
    Expert Rev Proteomics; 2016 Oct; 13(10):905-915. PubMed ID: 27598304
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Research progress in applying proteomics technology to explore early diagnosis biomarkers of breast cancer, lung cancer and ovarian cancer.
    Luo L; Dong LY; Yan QG; Cao SJ; Wen XT; Huang Y; Huang XB; Wu R; Ma XP
    Asian Pac J Cancer Prev; 2014; 15(20):8529-38. PubMed ID: 25374164
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Novel proteomic technologies to address gaps in pre-clinical ovarian cancer biomarker discovery efforts.
    Jordan HA; Thomas SN
    Expert Rev Proteomics; 2023; 20(12):439-450. PubMed ID: 38116719
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Protein biomarkers of ovarian cancer: the forest and the trees.
    Nolen BM; Lokshin AE
    Future Oncol; 2012 Jan; 8(1):55-71. PubMed ID: 22149035
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Network views for personalized medicine.
    Vlahou A
    Proteomics Clin Appl; 2013 Jun; 7(5-6):384-7. PubMed ID: 23532915
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Progress in ovarian cancer research: proceedings of the 5th Biennial Ovarian Cancer Research Symposium.
    Disis ML; Rivkin SE; Baron A; Markman M; Connolly D; Ueland F; Kohn E; Trimble E; Berek JS
    Int J Gynecol Cancer; 2006; 16(2):463-9. PubMed ID: 16681712
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Proteomics research in breast cancer: balancing discovery and hypothesis-driven studies.
    Veenstra TD
    Expert Rev Proteomics; 2011 Apr; 8(2):139-41. PubMed ID: 21501004
    [No Abstract]   [Full Text] [Related]  

  • 94. The role of proteomics in the diagnosis and treatment of ovarian cancer.
    Tchabo NE; Guancial EA; Czechowicz JA; Kohn EC
    Womens Health (Lond); 2005 Nov; 1(3):365-74. PubMed ID: 19803878
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Proteomic Biomarkers for the Detection of Endometrial Cancer.
    Njoku K; Chiasserini D; Whetton AD; Crosbie EJ
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31623106
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics.
    Engelberth SA; Hempel N; Bergkvist M
    Crit Rev Oncog; 2014; 19(3-4):281-315. PubMed ID: 25271436
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A decade of proteomics studies of glaucomatous neurodegeneration.
    Tezel G
    Proteomics Clin Appl; 2014 Apr; 8(3-4):154-67. PubMed ID: 24415558
    [TBL] [Abstract][Full Text] [Related]  

  • 98. From bio-molecular and technology innovations to clinical practice: focus on ovarian cancer.
    Legge F; Ferrandina G; Scambia G
    Ann Oncol; 2006 Jun; 17 Suppl 7():vii46-8. PubMed ID: 16760291
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Early detection of epithelial ovarian cancer using a proteomics-based protein-profiling approach combined with a novel selection strategy.
    Kothandaraman N; Bajic VB; Loganath A; Koh S; Ng J; Choolani M; Razvi K
    Ann Acad Med Singap; 2004 Sep; 33(5 Suppl):S59-60. PubMed ID: 15651211
    [No Abstract]   [Full Text] [Related]  

  • 100. Early detection of ovarian cancer. It isn't silent--it whispers, and patients and providers must listen carefully.
    Trouskova O; Alexander B
    Adv NPs PAs; 2012 Jan; 3(1):21-4; quiz 25. PubMed ID: 22355885
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.